Adrenal carcinoma screening tests are used to detect cancer in people who do not currently have any symptoms. However, screening tests are not widely used to check for adrenal tumors. Routine testing may be an option for individuals with Li-Fraumeni syndrome, Von Hippel-Lindau disease, or other genetic syndromes that are considered risk factors for adrenal carcinoma, but researchers are still determining the best approach to adrenal carcinoma screening for the general population.
The following tests may be recommended to people who are genetically predisposed to adrenal carcinoma:
- Physical examinations
- Imaging scans, including CT scans and ultrasounds, to visually examine a patient’s adrenal gland
- Blood and urine tests to check for elevated hormone levels
If one of these tests indicates that an adrenal carcinoma might be present, additional testing can then be ordered. For instance, a biopsy (tissue test) can be performed to determine if a growth on a patient’s adrenal gland is malignant or benign.
Because each person’s risk profile is different, screening plans often vary from one person to the next. At Moffitt Cancer Center, we offer individualized genetic counseling services to help patients determine the best screening options for their needs. We’re committed to improving early detection options for all forms of cancer, including adrenal carcinoma. As a result, patients can discuss their adrenal carcinoma screening options with a Moffitt oncologist with or without a referral.